Results 171 to 180 of about 34,373 (228)

The Genetic Polymorphisms of CYP2C9 and VKORC1 in the Saudi Population and Their Impact on Anticoagulant Management. [PDF]

Medicina (Kaunas)
Al Hamad M.
europepmc   +1 more source

Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications. [PDF]

Curr Ther Res Clin Exp
Yu J, Argon S, Owens K, Wang Y, Ragueneau-Majlessi I.   +4 more
europepmc   +1 more source

Exploring the roles of cytochrome P450 enzymes and their inhibitors in cancers and non-neoplastic human diseases. [PDF]

Arch Pharm Res
Lee H, Kwon YJ, Chun YJ.
europepmc   +1 more source

Clinical Application of Pharmacogenomics in Stroke Management: Current Evidence and Future Directions. [PDF]

J Stroke
Lee KJ, Kang M, Lee EJ, Oh J, Han NY, Lee JY, Lee JY, Lee SJ, Debette S, Paré G, Woo D, Eldeiry A, Kim YS, Kim J, Park JM, Lee J, Sung J, Choi JC, Bae HJ.   +18 more
europepmc   +1 more source

<i>CYP2C9</i> polymorphism is associated with susceptibility to ischemic stroke in a Chinese population. [PDF]

Ann Med
Zhang J, Jia H, Liu Y, Zhang Y, Nie H, Bao Q.   +5 more
europepmc   +1 more source

Phenoconversion of CYP2C9 in epilepsy limits the predictive value of CYP2C9 genotype in optimizing valproate therapy [PDF]

, 2015
Bűdi, Tamás, Háfra, Edit, Kiss, Ádám, Monostory, Katalin, Temesvári, Manna, Tóth, Katalin   +5 more
core   +1 more source

Investigating the effects of air pollution on papillary thyroid cancer based on network toxicology and molecular docking. [PDF]

Discov Oncol
Chen Z, Yang Y, Shen Y, Tan F, Mei K, Huang Y.   +5 more
europepmc   +1 more source

Protein Levels of 16 Cytochrome P450s and 2 Carboxyl Esterases Using Absolute Quantitative Proteomics: CYP2C9 and CYP3A4 Are the Most Abundant Isoforms in Human Liver and Intestine, Respectively. [PDF]

Pharmaceuticals (Basel)
Grangeon A, Arwood ML, Thacker D, Gaudette F, Turgeon J, Michaud V.   +5 more
europepmc   +1 more source

Prevalence of risk phenotypes associated with <i>CYP2C9*2, *3,</i> and <i>VKORC1 c.-1639G>A</i> genetic polymorphisms in world populations: implications in clinical practice. [PDF]

Front Pharmacol
Biswas M, Murad MA, Ershadian M, Kali MSK, Shin Sim M, Ibrahim B, Sukasem C.   +6 more
europepmc   +1 more source

Clinical Pharmacogenomic Variants Among the Saudi Population and Their Impact on Drug Response: A Review of Saudi-Based Evidence. [PDF]

Cureus
Alqurain A, Alshridha TI, Al-Otaibi S, Al-Otaibi DF, Douba FM, Aldhobaib AI, Alammar N, Khubrani MM, Althobaiti W, Alwashmi RM, Al-Aklabi FA, Alfahhad LS, Alkhouaiter KS, Alharbi GA, Almutairi RO.   +14 more
europepmc   +1 more source